Search for: "IMAGING ON CALL, LLC" Results 81 - 100 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Dec 2022, 9:01 pm by News Desk
In a Nov. 16, 2022, warning letter the FDA described an Oct. 2022, review of Infusionz, LLC’s website at the internet address “https://cbdinfusionz.com. [read post]
6 Dec 2022, 5:01 am by Eugene Volokh
Likewise, conservative Christian students may be upset at speech that calls their religious views bigoted or irrational. [read post]
3 Dec 2022, 8:30 am by Dale Carpenter
For example, elaborate custom wedding cakes adorned with specific symbols and pastry-gun writing are perhaps a close call. [read post]
19 Nov 2022, 11:17 am by Andrew Delaney
Therrien, 2022 VT 35       The week of July 22 had two opinions and what we’ll call an “addendum. [read post]
18 Nov 2022, 12:50 pm by Arianna Morseau
Kadiak LLC Operations Assistant. [read post]
18 Nov 2022, 3:00 am by Jay Butchko
The most basic requirement is that the individual must be a physician, psychologist, or psychiatrist who is called by SSA to be an objective witness about your disability. [read post]
4 Nov 2022, 7:56 am by OTy9gYz
Image Caption: “Dondi 1979 (IRT express train)” by JJ & Special K is licensed under CC-BY-SA 2.0 By Tokunbo Fashanu and Julianne Schmidt. [read post]
31 Oct 2022, 11:49 am by Rebecca Tushnet
CasperLabs, LLC, No. 21-CV-474 TWR (AHG), 2022 WL 14915618 (S.D. [read post]
21 Oct 2022, 4:00 am by Jim Sedor
Congressional Ethics Watchdog Calls for Ethics Investigation into Kahele Honolulu Civil Beat – Nick Grube | Published: 10/14/2022 The Office of Congressional Ethics called for an official inquiry into U.S. [read post]
27 Sep 2022, 7:38 am
If your breast cancer was misdiagnosed or your loved one died as a result of a misdiagnosis call [[phone]] for a free consultation. [read post]
26 Sep 2022, 12:20 pm by Verónica Rodríguez Arguijo
StockX LLC, Case No. 1:22-cv-00983, regarding trade mark infringement [read post]
26 Sep 2022, 4:49 am by Dennis Crouch
GlaxoSmithKline LLC, No. 22-37 This case delves deeply into the patent-FDA overlap and involves an increasingly common situation “skinny label” situation. [read post]